Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin- deficiency-related COPD

Respiration

Volumn 76, Issue 1, 2008, Pages 61-68

  Corda, Luciano ^a   Bertella, Enrica ^b   La Piana, Giuseppe Emanuele ^b   Boni, Enrico ^a   Redolfi, Stefania ^b   Tantucci, Claudio ^b  

^a Prima Divisione di Medicina   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

1 antitrypsin deficiency; Chronic obstructive pulmonary disease; Inhaled corticosteroids

Indexed keywords

BECLOMETASONE DIPROPIONATE; HELIOX; NORFLURANE; OXITROPIUM BROMIDE; PLACEBO; SALBUTAMOL; SALMETEROL;

ADD ON THERAPY; ADULT; AGED; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPNEA; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMAN; LUNG FUNCTION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; WALKING;

ADMINISTRATION, INHALATION; AGED; ALBUTEROL; ALPHA 1-ANTITRYPSIN DEFICIENCY; BECLOMETHASONE; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DYSPNEA; EXERCISE TOLERANCE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; SCOPOLAMINE DERIVATIVES;

EID: 46249098198     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000119718     Document Type: Article

References (25)

1. Stoller JK, Aboussouan LS: Alpha1-antitrypsin deficiency. Lancet 2005;365:2225-2236.
2. Strange C, Stoller JK, Sandhaus RA, Dickson R, Turino G: Results of a survey of patients with alpha-1 antitrypsin deficiency. Respiration 2006;73:185-190.
3. Wood AM, Stockley RA: Alpha one antitrypsin deficiency: from gene to treatment. Respiration 2007;74:481-492.
4. Yanai M, Sekizawa K, Ohrui T, Sasaki H, Takishima T: Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol 1992;72:1016-1023.
5. Tomashefski JF, Crystal RG, Wiedemann HP, Mascha E, Stoller JK: The bronchopulmonary pathology of alpha-1 antitrypsin (AAT) deficiency: findings of the Death Review Committee of the National Registry for Individuals with Severe Deficiency of Alpha-1 Antitrypsin. Hum Pathol 2004;35:1452-1461.
6. Cosio MG, Ghezzo H, Hogg JC, Corbin R, Loveland M, Dosman J, Macklem PT: The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 1978;298:1277-1281.
7. Cosio MG, Hale KA, Niewoehner DE: Morphologic and morphometric effects of prolonged cigarette smoking on the small airways. Am Rev Respir Dis 1980;122:265-271.
8. Rouhani F, Paone G, Smith NK, Krein P, Barnes P, Brantly ML: Lung neutrophil burden correlates with increased pro-inflammatory cytokines and decreased lung function in individuals with alpha(1)-antitrypsin deficiency. Chest 2000;117:S250-S251.
9. Stockley RA, Hill AT, Hill SL, Campbell EJ: Bronchial inflammation: its relationship to colonizing microbial load and alpha(1)-antitrypsin deficiency. Chest 2000;117:S291-S293.
10. Mahadeva R, Atkinson C, Li Z, Stewart S, Janciauskiene S, Kelley DG, Parmar J, Pitman R, Shapiro SD, Lomas DA: Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo. Am J Pathol 2005;2:377-386.
11. Wilcke JTR, Dirksen A: The effect of inhaled glucocorticosteroids in emphysema due to alpha1-antitrypsin deficiency. Respir Med 1997;91:275-279.
12. Leach CL, Davidson PJ, Boudreau RJ: Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998;12:1346-1353.
13. Marshall BG, Wangoo A, Harrison LI, Young DB, Shaw RJ: Tumor necrosis factor-alpha production in human alveolar macrophages: modulation by inhaled corticosteroid. Eur Respir J 2000;15:764-770.
14. Pauwels A, Buist S, Calverley PMA, Jenkins CR, Hurd SS, GOLD Scientific Committee: global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-1276.
15. American Thoracic Society: Standardization of spirometry: 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
16. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE: The development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992;47:1019-1024.
17. Chua F, Laurent GJ: Neutrophil elastase: mediator of extracellular matrix destruction and accumulation. Proc Am Thor Soc 2006;3:424-427.
18. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD: Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997;277:2002-2004.
19. Skold CM, Liu X, Umino T, Zhu Y, Ohkuni Y, Romberger DJ, Spurzem JR, Heires AJ, Rennard SI: Human neutrophil elastase augments fibroblast-mediated contraction of released collagen gels. Am J Respir Crit Care Med 1999;159:1138-1146.
20. Morrison HM, Kramps JA, Burnett D, Stockley RA: Lung lavage fluid from patients with alpha 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Clin Sci (Lond) 1987;72:373-381.
21. Hubbard RC, Fells G, Gadek J, Pacholok S, Humes J, Crystal RG: Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency: spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest 1991;88:891-897.
22. Woolhouse IS, Bayley DL, Stockley RA: Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8. Thorax 2002;57:709-714.
23. Elliott PR, Bilton D, Lomas DA: Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema. Am J Respir Cell Mol Biol 1998;18:670-674.
24. Lomas DA: The selective advantage of alpha1-antitrypsin deficiency. Am J Respir Crit Care Med 2006;173:1072-1077.
25. Parmar JS, Mahadeva R, Reed BJ, Farahi N, Cadwallader KA, Keogan MT, Bilton D, Chilvers ER, Lomas DA: Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema. Am J Respir Cell Mol Biol 2002;26:723-730.